These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8782006)

  • 1. Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects.
    Portincasa P; DiCiaula A; Palmieri V; Velardi A; Van Berge-Henegouwen GP; Palasciano G
    Ital J Gastroenterol; 1996; 28(2):111-3. PubMed ID: 8782006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid.
    Neubrand M; Sauerbruch T
    Z Gastroenterol; 1998 Apr; 36(4):267-71. PubMed ID: 9612923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severely impaired postprandial gallbladder emptying despite unchanged cholecystokinin release in the early phase of biliary colic.
    van Erpecum KJ; van Berge Henegouwen GP; Hopman WP; Jansen JB; Lamers CB
    Neth J Med; 1991 Jun; 38(5-6):188-92. PubMed ID: 1922590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of gallbladder emptying in gallstone patients after oral cholestyramine.
    Portincasa P; Di Ciaula A; Palmieri VO; Baldassarre G; Palasciano G
    Am J Gastroenterol; 1994 Jun; 89(6):909-14. PubMed ID: 8198104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution.
    Festi D; Frabboni R; Bazzoli F; Sangermano A; Ronchi M; Rossi L; Parini P; Orsini M; Primerano AM; Mazzella G
    Gastroenterology; 1990 Dec; 99(6):1779-85. PubMed ID: 2227291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.
    Sylwestrowicz TA; Shaffer EA
    Gastroenterology; 1988 Sep; 95(3):740-8. PubMed ID: 3396819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects.
    van Berge Henegouwen GP; Hofmann AF
    Gastroenterology; 1978 Nov; 75(5):879-85. PubMed ID: 700331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bile salts on in vitro gallbladder motility: preliminary study.
    Stolk MF; Van de Heijning BJ; Van Erpecum KJ; Verheem A; Akkermans LM; Van Berge-Henegouwen GP
    Ital J Gastroenterol; 1996; 28(2):105-10. PubMed ID: 8782005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of extracorporeal shock wave lithotripsy and ursodeoxycholic acid on gallbladder motility.
    Rothstein RD; Brugge WR; Malet PF
    Dig Dis Sci; 1993 Sep; 38(9):1712-7. PubMed ID: 8359085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation.
    Angelico M; Tisone G; Baiocchi L; Palmieri G; Pisani F; Negrini S; Anselmo A; Vennarecci G; Casciani CU
    Ital J Gastroenterol Hepatol; 1999; 31(6):462-8. PubMed ID: 10575563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects.
    van Erpecum KJ; van Berge Henegouwen GP; Stolk MF; Hopman WP; Jansen JB; Lamers CB
    Gastroenterology; 1990 Sep; 99(3):836-42. PubMed ID: 2199291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tauroursodeoxycholic acid on biliary lipid composition. A dose-response study.
    Muraca M; Vilei MT; Cianci V; Liu XT; Garotta F
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):391-3. PubMed ID: 7582394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic evaluation of resting gallbladder volume and postprandial emptying in patients with gallstones.
    Kishk SM; Darweesh RM; Dodds WJ; Lawson TL; Stewart ET; Kern MK; Hassanein EH
    AJR Am J Roentgenol; 1987 May; 148(5):875-9. PubMed ID: 3554918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management.
    Redfern JS; Fortuner WJ
    Am J Gastroenterol; 1995 Jul; 90(7):1042-52. PubMed ID: 7611194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.
    Azzaroli F; Mazzella G; Mazzeo C; Simoni P; Festi D; Colecchia A; Montagnani M; Martino C; Villanova N; Roda A; Roda E
    Am J Gastroenterol; 1999 Sep; 94(9):2453-9. PubMed ID: 10484008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying.
    Forgacs IC; Maisey MN; Murphy GM; Dowling RH
    Gastroenterology; 1984 Aug; 87(2):299-307. PubMed ID: 6329890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, placebo-controlled ultrasonographic study.
    Portincasa P; Altomare DF; Moschetta A; Baldassarre G; Di Ciaula A; Venneman NG; Rinaldi M; Vendemiale G; Memeo V; vanBerge-Henegouwen GP; Palasciano G
    Am J Gastroenterol; 2000 Dec; 95(12):3444-51. PubMed ID: 11151875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ursodeoxycholic acid in the treatment of gallbladder lithiasis].
    Mamianetti A; Labonia NA; Lafont D; Fiordalisi HH
    Acta Gastroenterol Latinoam; 1982; 12(1):33-8. PubMed ID: 7136453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol induces gallbladder contraction during fasting, but does not influence postprandial emptying: an ultrasound study in healthy subjects.
    Acalovschi M; Dumitrascu DL; Suteu T; Veres A; Albu S; Badea RI
    Acta Gastroenterol Belg; 2002; 65(4):191-5. PubMed ID: 12619424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids.
    Bazzoli F; Festi D; Mazzella G; Frabboni R; Zagari RM; Fossi S; Pozzato P; Sottili S; Simoni P; Roda A
    Am J Gastroenterol; 1995 Jun; 90(6):978-81. PubMed ID: 7771434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.